Peripheral Vascular Diagnostic Systems Market Size, Share, Growth, and Industry Analysis, By Type (Diabetes and Critical Limb Ischemia), By Application (Hospital, Clinic and Other), and Regional Forecast From 2026 To 2035

• 

  Download Free Sample to learn more about this report

PERIPHERAL VASCULAR DIAGNOSTIC SYSTEMS MARKET OVERVIEW

The global Peripheral Vascular Diagnostic Systems Market is valued at approximately USD 0.59 Billion in 2026 and is projected to reach USD 1.08 Billion by 2035. It grows at a compound annual growth rate (CAGR) of around 7% from 2026 to 2035.

The Peripheral Vascular Diagnostic Systems Market is expanding due to the increasing global burden of peripheral artery disease affecting more than 230 million people worldwide, with nearly 20% prevalence among populations above 80 years of age. Peripheral vascular diagnostic systems including ankle-brachial index systems, Doppler ultrasound devices, pulse volume recording systems, and segmental pressure measurement equipment are witnessing strong demand across hospitals and vascular clinics. More than 68% to 84% sensitivity rates are reported for ankle-brachial index testing in peripheral artery disease diagnosis, while specificity levels range between 84% and 99%. Automated diagnostic systems adoption increased by 27% between 2021 and 2025 because healthcare facilities are emphasizing noninvasive vascular assessment procedures.

The United States Peripheral Vascular Diagnostic Systems Market represents a major share of global installations due to the presence of more than 8.5 million individuals diagnosed with peripheral artery disease. Nearly 96% of diagnosed cases are linked to at least 1 cardiovascular risk factor including diabetes, smoking, hypertension, or obesity. Medicare-supported vascular screening procedures increased by 19% between 2022 and 2025, while hospital demand for automated ankle-brachial index systems expanded by 24% during the same period. Approximately 65% of vascular laboratories in the United States now utilize Doppler-based vascular diagnostic systems for routine screening. More than 42% of U.S. vascular clinics adopted portable vascular diagnostic devices in 2024 to improve outpatient screening efficiency.

KEY FINDINGS

LATEST TRENDS

The Peripheral Vascular Diagnostic Systems Market is experiencing rapid technological advancement driven by increasing rates of diabetes, obesity, and cardiovascular disorders. More than 537 million adults worldwide currently live with diabetes, and nearly 30% of diabetic patients develop peripheral vascular complications requiring continuous vascular assessment. Automated ankle-brachial index systems are increasingly replacing manual diagnostic methods, with automated device adoption rising by 35% between 2022 and 2025. Portable vascular diagnostic systems now represent approximately 46% of newly installed systems because outpatient diagnostic procedures increased by 22% globally.

Artificial intelligence integration in peripheral vascular diagnostic systems improved waveform interpretation accuracy by nearly 18% during 2024 clinical evaluations. Wireless data transfer functionality has been integrated into approximately 41% of newly launched systems, improving remote patient monitoring capabilities across vascular clinics. Doppler ultrasound systems continue dominating the Peripheral Vascular Diagnostic Systems Market due to their 84% to 99% specificity in peripheral artery disease detection. Hospitals account for nearly 52% of global installations because inpatient vascular assessments increased by 17% between 2023 and 2025. Asia-Pacific demonstrated the fastest installation growth, with diagnostic device procurement rising by 31% due to increasing chronic disease prevalence and expanding hospital infrastructure.

Download Free Sample to learn more about this report

PERIPHERAL VASCULAR DIAGNOSTIC SYSTEMS MARKET SEGMENTATION

By Type Analysis

• Diabetes : Diabetes-related vascular complications represent one of the largest segments within the Peripheral Vascular Diagnostic Systems Market because more than 537 million adults worldwide currently live with diabetes. Nearly 30% of diabetic individuals experience peripheral vascular abnormalities, increasing demand for routine vascular screening systems. Automated ankle-brachial index systems account for approximately 44% of diabetes-related vascular assessments due to their rapid screening capability. Doppler ultrasound devices are widely utilized in diabetic foot evaluation because sensitivity levels exceed 70% for lower limb circulation assessment. 

• Critical Limb Ischemia : Critical limb ischemia represents a high-priority segment within the Peripheral Vascular Diagnostic Systems Market because severe arterial obstruction significantly increases amputation risks. Nearly 11% of patients diagnosed with peripheral artery disease progress toward critical limb ischemia during advanced disease stages. Diagnostic systems including toe-brachial index analyzers, pulse volume recording devices, and transcutaneous oxygen measurement systems are increasingly utilized for severe vascular assessment. More than 39% of vascular surgery departments integrated advanced Doppler imaging systems during 2024 to improve critical limb ischemia diagnosis accuracy. 

By Application Analysis

• Hospital : Hospitals dominate the Peripheral Vascular Diagnostic Systems Market with nearly 52% market share because inpatient cardiovascular and vascular surgery departments require continuous arterial assessment technologies. More than 65% of tertiary care hospitals utilize Doppler ultrasound systems for routine peripheral vascular examinations. Automated ABI systems have been installed in approximately 49% of cardiovascular departments due to growing emphasis on early-stage peripheral artery disease diagnosis. Inpatient vascular diagnostic procedures increased by 17% between 2023 and 2025 because of rising diabetic admissions and cardiovascular complications. 

• Clinic : Clinics account for approximately 33% of the Peripheral Vascular Diagnostic Systems Market due to growing outpatient vascular testing demand. Portable ABI and handheld Doppler systems are widely used in vascular clinics because diagnostic turnaround times improved by nearly 22% with compact systems. More than 42% of outpatient vascular clinics integrated wireless diagnostic systems during 2024 to improve patient data management efficiency. Diabetes-focused clinics contribute significantly to peripheral vascular testing demand because approximately 28% of diabetic patients require annual lower limb circulation evaluation.

• Other : Other healthcare settings including ambulatory surgical centers, rehabilitation centers, and community healthcare units account for nearly 15% of the Peripheral Vascular Diagnostic Systems Market. Ambulatory centers reported a 21% increase in peripheral vascular testing procedures during 2024 due to the growing preference for same-day diagnostic evaluations. Community healthcare facilities increasingly utilize portable Doppler devices because compact systems reduced screening times by approximately 18%. More than 31% of rehabilitation centers integrated vascular circulation monitoring systems for post-surgical patient assessment. 

MARKET DYNAMICS

Driving Factor

Rising prevalence of peripheral artery disease and diabetes-related vascular complications

The increasing prevalence of peripheral artery disease is the strongest driver for the Peripheral Vascular Diagnostic Systems Market. More than 230 million individuals globally are affected by peripheral artery disease, while approximately 20% of people above 80 years experience vascular circulation impairment. Diabetes contributes significantly to vascular complications, with nearly 30% of diabetic patients developing lower extremity vascular disorders. Hospitals reported a 26% increase in vascular screening procedures between 2021 and 2025 because of higher cardiovascular disease incidence.

Ankle-brachial index testing remains the primary diagnostic approach due to sensitivity rates ranging from 68% to 84%. More than 58% of vascular diagnostic procedures are conducted among patients aged above 60 years. The growing prevalence of smoking-related vascular complications, affecting nearly 18% of chronic smokers, is further supporting demand for peripheral vascular diagnostic systems market analysis and diagnostic equipment procurement.

Restaining Factor

High cost of advanced vascular diagnostic equipment and maintenance

The Peripheral Vascular Diagnostic Systems Market faces operational challenges because advanced Doppler ultrasound systems and integrated vascular imaging equipment involve high procurement and servicing expenses. Approximately 37% of small healthcare facilities delayed technology replacement cycles due to rising maintenance costs. Portable diagnostic systems reduced operational burden by nearly 21%, yet advanced AI-enabled vascular platforms still require significant software integration investments. Nearly 29% of rural hospitals lack dedicated vascular laboratories, limiting widespread adoption of high-end peripheral vascular diagnostic systems.

Training limitations also impact equipment utilization because approximately 32% of healthcare facilities reported shortages of certified vascular technologists in 2024. Replacement component expenses increased by 14% between 2023 and 2025 due to semiconductor supply limitations. These factors continue restricting adoption across low-resource healthcare environments despite increasing disease prevalence.

Expansion of portable and AI-integrated diagnostic systems

Opportunity

The growing shift toward portable and point-of-care diagnostic technologies presents strong opportunities for the Peripheral Vascular Diagnostic Systems Market. Portable ABI and Doppler systems represented nearly 46% of all new installations in 2025 because outpatient vascular testing increased by 24%. 

Telemedicine-compatible vascular systems expanded by 28% between 2023 and 2025 due to rising remote healthcare adoption. Asia-Pacific countries increased investments in vascular screening infrastructure by nearly 33%, creating opportunities for manufacturers offering compact and battery-operated systems. 

Limited awareness and underdiagnosis of peripheral artery disease

Challenge

Underdiagnosis remains a major challenge in the Peripheral Vascular Diagnostic Systems Market because only 10% to 20% of patients with peripheral artery disease experience classic intermittent claudication symptoms. More than 40% of patients remain undiagnosed during early-stage disease progression due to asymptomatic vascular impairment.

In primary healthcare settings, ABI screening utilization remains below 35% despite guideline recommendations for high-risk populations. Rural healthcare facilities account for nearly 31% lower vascular diagnostic testing rates compared to urban hospitals. Lack of awareness among patients and healthcare providers continues delaying timely diagnosis and treatment initiation.

• Download Free Sample to learn more about this report

•  

PERIPHERAL VASCULAR DIAGNOSTIC SYSTEMS MARKET REGIONAL INSIGHTS

• North America

North America dominates the Peripheral Vascular Diagnostic Systems Market with nearly 38% market share due to advanced healthcare infrastructure, increasing cardiovascular disease prevalence, and strong adoption of noninvasive diagnostic technologies. The United States represents the largest regional contributor because more than 8.5 million Americans are affected by peripheral artery disease. Nearly 65% of vascular laboratories in North America utilize Doppler ultrasound systems for routine arterial evaluation. Automated ABI systems installations increased by 29% between 2022 and 2025 because hospitals are emphasizing rapid vascular screening workflows. Canada contributes approximately 11% of North American installations due to growing geriatric populations and preventive healthcare initiatives. More than 54% of cardiovascular departments in major hospitals now integrate pulse volume recording systems and wireless diagnostic platforms. 

• Europe

Europe accounts for nearly 29% of the Peripheral Vascular Diagnostic Systems Market due to increasing aging populations and high awareness regarding cardiovascular disease prevention. More than 20% of Europe’s population is above 65 years of age, significantly increasing peripheral artery disease risk. Germany, France, and the United Kingdom collectively contribute approximately 57% of regional diagnostic equipment installations. Automated vascular screening procedures increased by 22% across European hospitals between 2022 and 2025.The European healthcare system strongly supports noninvasive diagnostics, with approximately 61% of vascular clinics utilizing ABI testing as a primary screening method. Doppler ultrasound devices remain dominant, accounting for nearly 46% of total vascular diagnostic systems used across Europe. Peripheral vascular disease prevalence among elderly Europeans exceeded 18% during 2024, increasing demand for continuous vascular monitoring technologies. 

• Asia-Pacific

Asia-Pacific represents approximately 24% of the Peripheral Vascular Diagnostic Systems Market and demonstrates the fastest growth in device installations due to rapidly increasing diabetes prevalence and healthcare infrastructure development. China and India together account for more than 43% of regional demand because both countries have large diabetic populations. Diabetes prevalence exceeded 10% among adults in several Asia-Pacific countries during 2024, significantly increasing peripheral vascular screening requirements. Hospitals in Asia-Pacific reported a 31% increase in procurement of portable vascular diagnostic systems between 2022 and 2025 because outpatient screening programs expanded across urban healthcare networks. Japan and South Korea maintain advanced vascular diagnostic adoption rates, with nearly 58% of tertiary hospitals utilizing integrated Doppler and ABI systems. 

• Middle East & Africa

The Middle East & Africa region accounts for nearly 9% of the Peripheral Vascular Diagnostic Systems Market due to improving healthcare investments and increasing cardiovascular disease awareness. Gulf Cooperation Council countries contribute approximately 61% of regional installations because healthcare modernization initiatives expanded diagnostic infrastructure significantly between 2022 and 2025. Diabetes prevalence exceeded 16% in several Gulf countries, increasing demand for peripheral vascular diagnostic procedures. Hospitals across the Middle East reported a 19% increase in Doppler ultrasound system installations during 2024 due to rising vascular disease screening initiatives. South Africa represents approximately 18% of African market demand because tertiary healthcare facilities increasingly integrate portable ABI systems. Rural healthcare access limitations continue impacting regional growth, with nearly 34% of healthcare facilities lacking dedicated vascular diagnostic laboratories. 

LIST OF TOP PERIPHERAL VASCULAR DIAGNOSTIC SYSTEMS COMPANIES

• ArjoHuntleigh
• Viasonix
• OMRON Healthcare
• Opto Circuits
• ACI Medical Management
• BioMedix
• Dialog Devices
• D.E. Hokanson
• ELCAT
• FUKUDA DENSHI
• Koven Technology
• LD Technology
• MGC Diagnostics

Top 2 Companies with Highest Market Share:

• OMRON Healthcare holds approximately 16% share in automated vascular diagnostic monitoring systems due to its extensive distribution network across more than 110 countries and increasing adoption of portable ABI diagnostic devices.

• Viasonix accounts for nearly 13% share in advanced Doppler ultrasound and vascular assessment systems because its integrated diagnostic platforms are utilized across more than 4,000 vascular laboratories globally.

INVESTMENT ANALYSIS AND OPPORTUNITIES

The Peripheral Vascular Diagnostic Systems Market is attracting increasing investments due to the rising burden of peripheral artery disease, diabetes, and cardiovascular disorders. Healthcare facilities expanded vascular diagnostic equipment procurement by approximately 24% between 2022 and 2025. More than 41% of investments focused on portable diagnostic systems because outpatient vascular testing volumes increased substantially. Venture capital participation in AI-based diagnostic technologies increased by 28% during 2024 due to demand for automated waveform interpretation and cloud-connected vascular assessment platforms.

North America accounted for nearly 39% of total investment activity because hospital modernization programs continue prioritizing cardiovascular screening technologies. Asia-Pacific experienced approximately 33% growth in healthcare infrastructure investments supporting noninvasive diagnostic systems. Governments and private healthcare organizations are emphasizing preventive cardiovascular care, resulting in a 23% increase in routine vascular screening programs globally.

NEW PRODUCT DEVELOPMENT

New product development in the Peripheral Vascular Diagnostic Systems Market is primarily focused on portability, automation, and AI-assisted diagnostics. More than 32% of newly launched vascular diagnostic systems during 2024 included wireless connectivity and cloud-based patient data management functions. Automated ankle-brachial index systems reduced examination time by approximately 21% compared to manual diagnostic procedures. Portable Doppler systems represented nearly 46% of new product launches because outpatient diagnostic demand continues increasing globally.

Manufacturers are emphasizing compact designs and battery-operated technologies to improve rural healthcare accessibility. AI-integrated waveform analysis systems improved diagnostic interpretation accuracy by nearly 18% during clinical testing programs conducted in 2024. Several newly developed systems now support touchscreen interfaces and automated report generation, reducing administrative workload by approximately 16% in vascular laboratories.

FIVE RECENT DEVELOPMENTS (2023-2025)

• In 2024, automated ABI diagnostic systems adoption increased by 34% across vascular clinics due to improved screening efficiency and reduced testing time by approximately 21%.
• During 2025, portable Doppler ultrasound device launches expanded by 28%, with nearly 41% of newly introduced systems integrating wireless patient data transfer capabilities.
• In 2023, AI-assisted waveform interpretation technology improved diagnostic accuracy by approximately 18% during multicenter vascular evaluation programs.
• Between 2023 and 2025, hospital procurement of portable vascular diagnostic systems increased by 31% because outpatient peripheral artery disease screening volumes rose significantly.
• In 2024, cloud-connected vascular diagnostic platforms accounted for nearly 25% of newly installed systems across tertiary healthcare facilities due to rising demand for remote patient monitoring.

REPORT COVERAGE

The Peripheral Vascular Diagnostic Systems Market Report provides comprehensive analysis of industry trends, product innovations, regional demand patterns, and competitive developments across global healthcare markets. The report evaluates diagnostic technologies including ankle-brachial index systems, Doppler ultrasound devices, pulse volume recording systems, and transcutaneous oxygen monitoring equipment. More than 15 countries were analyzed to assess installation trends, healthcare infrastructure development, and peripheral artery disease prevalence.

The Peripheral Vascular Diagnostic Systems Market Research Report includes segmentation analysis by type, application, and region, covering hospitals, clinics, ambulatory centers, and rehabilitation facilities. Approximately 52% of market demand originates from hospital-based vascular diagnostics, while portable systems contribute nearly 46% of newly installed equipment globally. The report examines the impact of diabetes prevalence exceeding 10% in multiple countries and increasing peripheral vascular disease incidence among populations above 65 years.